Komori
Tomoegawa (3878) · PolicyRestatedLatest Financial results presentation (2026-05-15): "Reframed"

Allocation of Retained Earnings to Research and Development and Capital Investment

First written in FY2017. 1 of 3 entries say "Restated". Latest entry: 2026-05-15.

3entries
10years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017 – FY20202017: 120172018: 020182019: 020192020: 120202021: 020212022: 020222023: 020232024: 020242025: 020252026: 12026
Same theme, other companies
Investment in Products, Technology, and Production Capacity Using Retained EarningsA theme 113 companies write about · 0 as a headwind · 113 as a tailwind

Tomoegawa moved to the "Worse" side of this theme in 2026, the same year as the typical company in this theme.

The whole theme swung hardest in 2025: 6 of 60 companies on the "Worse" side.

6 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 113 companies compared. The sentences above are computed from all 113.
Full recordFilings, disclosures and news, newest first
  1. 2026-05-15ReframedFinancial results presentation

    「While balancing growth investment, comprising capital investment and research and development investment, with shareholder returns as our basic policy, for the time being we intend to prioritise the allocation of operating cash flow to proactive growth investment, secure working capital for emergencies, and allocate surplus funds to shareholder returns.」

    In addition to allocating funds to research and development and capital investment, the company indicated that it would prioritise operating cash flow for growth investment for the time being and allocate surplus funds to shareholder returns.
  2. FY2020RestatedAnnual report

    「Retained earnings are allocated to research and development of new products and technologies and capital investment to address changes in the business environment, thereby maintaining and strengthening the company's competitiveness and seeking to enhance shareholder value.」

    The company continues its policy of allocating retained earnings to research and development and capital investment to strengthen competitiveness and enhance shareholder value.
  3. FY2017First statedAnnual report

    「Retained earnings are allocated to research and development of new products and technologies and capital investment to address changes in the business environment, thereby maintaining and strengthening the company's competitiveness and seeking to enhance shareholder value.」

    The company states its policy of using retained earnings for research and development of new products and technologies and capital investment to maintain and strengthen competitiveness and enhance shareholder value.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Tomoegawa's next results are scheduled for 2026-11-10. Read the earnings preview It last moved in the Financial results presentation of 2026-05-15: "Reframed".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.